Ascendant Dx Closes $2M Funding Round, Adds Board Members

Ascendant Dx of Fayetteville, has developed an early detection test for breast cancer, closes a $2 million funding round and adds two members to its board of directors.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.

This is an ad. Please don't block. :)